학술논문
Obinutuzumab (GA101) plus chlorambucil (Clb) versus rituximab plus Clb in patients with chronic lymphocytic leukaemia (CLL) and comorbidities: recently published results of the CLL11 trial: 36
Document Type
Academic Journal
Author
Source
British Journal of Haematology. May 01, 2014 165 Suppl 1:19-19
Subject
Language
English
ISSN
0007-1048